申请人:Chen Christine Hiu-Tung
公开号:US20150126513A1
公开(公告)日:2015-05-07
The present invention provides for compounds of formula (I):
wherein R
1
-R
4
and n are defined herein. The present invention also provides for pharmaceutical compositions and combinations comprising a compound of formula (I) as well as for the use of such compounds as tankyrase inhibitors and in the treatment of Wnt signaling and tankyrase 1 and 2 signaling related disorders which include, but are not limited to, cancer.
本发明提供了公式(I)的化合物:其中R1-R4和n在此定义。本发明还提供了包括公式(I)化合物的制药组合物和组合物,以及将这些化合物用作坦克酰酶抑制剂,并用于治疗与Wnt信号和坦克酰酶1和2信号相关的疾病,包括但不限于癌症。